PRPH
ProPhase Labs Inc

2,447
Loading...
Loading...
News
all
press releases
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
Dave Collum's 2024 Year In Review, Part 1: What Is A Fact?
Dave Collum's 2024 Year In Review, Part 1: What Is A Fact? Authored by David B. Collum, Betty R. Miller Professor of Chemistry and Chemical Biology - Cornell University (Email...
Zero Hedge·9mo ago
News Placeholder
ProPhase Labs's Earnings: A Preview
read more...
Benzinga·10mo ago
News Placeholder
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) ( ProPhase or the Company ), a next-generation biopharma, genomics, and diagnostics company, today announced...
Globe Newswire·1y ago
News Placeholder
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase...
Globe Newswire·1y ago
News Placeholder
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
Nebula Genomics secures major international B2B deal Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion set for...
Globe Newswire·2y ago

Latest PRPH News

View

Advertisement. Remove ads.

Advertisement. Remove ads.